到 2028 年北美品牌仿制药市场预测 – COVID-19 影响和区域分析 – 按治疗应用(肿瘤学、心血管疾病、糖尿病、神经病学、胃肠道疾病、皮肤病、镇痛药和抗炎药等),分销渠道(医院、零售药店、网上药店和药店)、药品类别(烷化剂、抗代谢药、激素、抗高血压药、降脂药、抗抑郁药、抗精神病药、抗癫痫药等)和制剂类型(口服、肠外注射) 、专题和其他)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028


No. of Pages: 169    |    Report Code: BMIRE00026327    |    Category: Life Sciences

North America Branded Generics Market

北美品牌仿制药市场预计将从 2022 年的 731.5 亿美元增长到 2028 年的 1,262.4 亿美元;预计 2022 年至 2028 年复合年增长率为 9.5%。

 

品牌仿制药的渗透率不断提高北美品牌仿制药市场的增长。根据 VOXEU 的一份报告,在医疗保健预算面临压力的情况下,改用品牌仿制药似乎自然可以节省成本。品牌仿制药是品牌药物的更便宜的替代品。此外,根据 FDA 的数据,2020 年美国超过 90% 的处方药都是仿制药。此外,根据无障碍医学协会的数据,2020 年仿制药和生物仿制药节省了 1 美元。美国3380亿。此外,美国医疗保健支出同年增长9.7%,达到4.1万亿美元。此外,由于低成本仿制药的出现,过去十年美国医疗保健支出节省了 2.2 万亿美元。

 

此外,无障碍药物协会报告指出,2018 年发放了近 40 亿张仿制药处方。根据 HSRII 报告,美国是世界上最大的药品市场(3,250 亿美元),占全球药品市场的 1-仿制药占整个药品市场的第三位,按销售额计占 84%,按销售额计占 28%。此外,由于低成本替代品和医疗报销系统的节省,品牌仿制药的使用在人群中有所增加。平均而言,2019 年,仿制药的使用为医疗保险节省了 930 亿美元,为医疗补助节省了 485 亿美元。因此,仿制药渗透率的上升刺激了整个品牌仿制药市场的增长。

 

通过引入新功能和技术,供应商北美品牌仿制药市场可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会在预测期内推动市场实现良好的复合年增长率。

 

北美品牌仿制药

 

2028 年市场收入及预测(十亿美元)

 

 

 

北美品牌仿制药市场细分

 

北美品牌仿制药市场根据治疗应用、分销渠道、药物类别、配方类型和国家/地区进行细分。根据治疗应用,市场分为肿瘤、心血管疾病、糖尿病、神经病学、胃肠道疾病、皮肤病、镇痛抗炎药。到 2022 年,其他细分市场将占据最大的市场份额。按分销渠道划分,市场分为医院药房、零售药房、网上药房和药店。到2022年,零售药房市场占据最大份额。北美品牌仿制药市场根据药物类别分为烷化剂、抗代谢药、激素、抗高血压、降脂药、抗抑郁药、抗抑郁药、精神病药、抗癫痫药等。到 2022 年,其他细分市场将占据最大的市场份额。根据制剂类型,市场分为口服、肠胃外、外用和其他。到2022年,口腔细分市场将占据最大的市场份额。根据国家/地区,北美品牌仿制药市场分为美国、加拿大和墨西哥。 2022 年,美国将占据最大的市场份额。

 

Aspen Holdings、阿斯利康、Bausch Health(Valeant Pharmaceuticals)、Dr. Reddy\'s Laboratories Inc .、葛兰素史克公司、Hetero、Lupin、MYLAN NV、Par Pharmaceuticals、Sandoz International Gmbh、赛诺菲和 TEVA PHARMACEUTICAL INDUSTRIES LTD。是该地区品牌仿制药市场的领先公司之一。  



North America Branded Generics Strategic Insights

Strategic insights for North America Branded Generics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/north-america-branded-generics-market-strategic-framework.webp
Get more information on this report

North America Branded Generics Report Scope

Report Attribute Details
Market size in 2022 US$ 73.15 Billion
Market Size by 2028 US$ 126.24 Billion
Global CAGR (2022 - 2028) 9.5%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By 治疗应用
  • 肿瘤科
  • 心血管疾病
  • 糖尿病
  • 神经科
  • 胃肠道疾病
  • 皮肤病
  • 镇痛消炎
By 分销渠道
  • 医院
  • 零售药店
  • 网上药店
  • 药店
By 药物类别
  • 烷化剂
  • 抗代谢药
  • 激素
  • 抗高血压药
  • 降脂药
  • 抗抑郁药
  • 抗精神病药
  • 抗癫痫药
By 剂型类型
  • 口服
  • 肠胃外
  • 外用
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
Market leaders and key company profiles
  • Aspen Holdings
  • AstraZeneca
  • Bausch Health (Valeant Pharmaceuticals)
  • Dr. Reddys Laboratories Inc.
  • GlaxoSmithKline plc
  • Hetero
  • Lupin
  • Mylan N.V.
  • Par Pharmaceuticals
  • Sandoz International Gmbh
  • Get more information on this report

    North America Branded Generics Regional Insights

    The regional scope of North America Branded Generics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/north-america-branded-generics-market-geography.webp
    Get more information on this report

    The List of Companies - North America Branded Generics Market

    1. Aspen Holdings
    2. AstraZeneca
    3. Bausch Health (Valeant Pharmaceuticals)
    4. Dr. Reddy's Laboratories Inc.
    5. GlaxoSmithKline plc
    6. Hetero
    7. Lupin
    8. Mylan N.V.
    9. Par Pharmaceuticals
    10. Sandoz International Gmbh
    11. Sanofi
    12. Teva Pharmaceutical Industries Ltd.
    Frequently Asked Questions
    How big is the North America Branded Generics Market?

    The North America Branded Generics Market is valued at US$ 73.15 Billion in 2022, it is projected to reach US$ 126.24 Billion by 2028.

    What is the CAGR for North America Branded Generics Market by (2022 - 2028)?

    As per our report North America Branded Generics Market, the market size is valued at US$ 73.15 Billion in 2022, projecting it to reach US$ 126.24 Billion by 2028. This translates to a CAGR of approximately 9.5% during the forecast period.

    What segments are covered in this report?

    The North America Branded Generics Market report typically cover these key segments-

  • 治疗应用 (肿瘤科, 心血管疾病, 糖尿病, 神经科, 胃肠道疾病, 皮肤病, 镇痛消炎)
  • 分销渠道 (医院, 零售药店, 网上药店, 药店)
  • 药物类别 (烷化剂, 抗代谢药, 激素, 抗高血压药, 降脂药, 抗抑郁药, 抗精神病药, 抗癫痫药)
  • What is the historic period, base year, and forecast period taken for North America Branded Generics Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Branded Generics Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in North America Branded Generics Market?

    The North America Branded Generics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Aspen Holdings
  • AstraZeneca
  • Bausch Health (Valeant Pharmaceuticals)
  • Dr. Reddys Laboratories Inc.
  • GlaxoSmithKline plc
  • Hetero
  • Lupin
  • Mylan N.V.
  • Par Pharmaceuticals
  • Sandoz International Gmbh
  • Sanofi
  • Teva Pharmaceutical Industries Ltd.
  • Who should buy this report?

    The North America Branded Generics Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Branded Generics Market value chain can benefit from the information contained in a comprehensive market report.